drugset / Trial / NCT00456833
Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study aims to assess the value of combined treatment with RAD001 and erlotinib in patients with advanced Non Small Cell Lung Cancer treated only with chemotherapy as systemic therapy.
Timeline
- Start
- 2005-06
- Primary completion
- 2011-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | 5 mg | — |
| Comparator | Erlotinib | Small molecule | 150 mg | — |